GLUL and plasma cell myeloma: These same studies also revealed that the inhibition of glutamine synthetase can detrimentally impact the survival impact myeloma cell lines and can increase the cytotoxic effects of HDAC inhibitors, which are commonly used in multiple myeloma treatment [14].